许从飞 副教授（博导）

省级青年人才项目入选者

办公电话:

  020-81182180

电子邮件:

xucf@scut.edu.cn

办公地址：

广州国际校区C1-c809

实验室网站链接：https://www2.scut.edu.cn/nanomedicine/yjtdcy/list.htm

2019-至今 华南理工大学生物医学科学与工程学院 副教授

2017-2019 华南理工大学 博士后

2012-2017 中国科学技术大学 博士

2008-2012 中国科学技术大学 学士

生物医学工程（学博、学硕）、生物学（学博、学硕）、材料与化工（工程博士）、药学（专硕） 

生物医用高分子材料、药物递送载体、基因编辑、基因治疗

共发表SCI论文48篇，论文总引用次数＞3800次；以第一作者或者通讯作者在Nature Communications、Science Bulletin、Nano Today、Nano Letters、ACS Nano、Small、Biomaterials、Advanced Drug Delivery Reviews等杂志发表SCI论文25篇，3篇入选ESI高被引论文；授权发明专利4项。

代表性论文：

1.Gui Zhao#, Yue Zhang#, Cong-Fei Xu*, Jun Wang*,In vivo production of CAR-T cells using virus-mimetic fusogenic nanovesicles, ScienceBulletin, 2024, 69(3), 354−366.

2.Yue Wang#, Shi-Kun Zhou#, YanWang, Zi-Dong Lu, Yue Zhang, Cong-Fei Xu*,Jun Wang*, Engineering tumor-specific gene nanomedicine to recruitand activate T cells for enhanced immunotherapy, Nature Communications,2023, 14, 1993.

3.Yue Zhang#, Gui Zhao#, Jing Liu, Hou-Bing Zhang, Yue Wang, Ying-LiLuo, Zi-Dong Lu, Xiao-Jiao Du, Song Shen, Jin-Zhi Du, Cong-Fei Xu*,Jun Wang*, Gene-activating nanomedicine for thetumor-oriented infiltration of T cells to enhance immunotherapy against solidtumors, Nano Today, 2023, 52, 101992.

4.Yue Zhang#, Gui Zhao#, Yi-Fang Chen, Shi-KunZhou, Yue Wang, Yi-Qun Sun, Song Shen, Cong-Fei Xu*, Jun Wang*,Engineering nano-clusteredmultivalent agonists to cross-link TNF receptors for cancer therapy, Aggregate,2023, 4(6), e393.

5.Cong-Fei Xu#, Guo-Jun Chen#, Ying-Li Luo, Yue Zhang, Gui Zhao, Zi-Dong Lu,Anna Czarna, Zhen Gu*, Jun Wang*, Rational designs of invivo CRISPR-Cas delivery systems, Advanced Drug Delivery Reviews, 2021, 168, 3−29.

6.Yue Zhang#, Song Shen#, Gui Zhao, Cong-Fei Xu*, Hou-Bing Zhang, Ying-Li Luo, Zhi-TingCao, Jia Shi, Zhi-Bin Zhao, Zhe-Xiong Lian, Jun Wang*, In situ repurposing of dendritic cells withCRISPR/Cas9-based nanomedicine to induce transplant tolerance, Biomaterials, 2019, 217, 119302.

7.Cong-Fei Xu#, Dong-Dong Li#, Zhi-Ting Cao, Meng-Hua Xiong, Xian-Zhu Yang*,Jun Wang*, Facile hydrophobization of siRNA with anticancer drug fornon-cationic nanocarrier-mediated systemic delivery, Nano Letters, 2019,19, 2688−2693.

8.Cong-Fei Xu, Shoaib Iqbal, Song Shen, Ying-Li Luo, Xian-Zhu Yang*, Jun Wang*,Development of “CLAN” nanomedicine for nucleic acid therapeutics, Small, 2019, 15, e1900055.

9.Cong-Fei Xu#, Zi-Dong Lu#, Ying-Li Luo, Yang Liu,Zhi-Ting Cao, Song Shen, Hong-Jun Li, Jing Liu, Kai-Ge Chen, Zhi-Yao Chen,Xian-Zhu Yang, Zhen Gu, Jun Wang*, Targeting of NLRP3 inflammasomewith gene editing for the amelioration of inflammatory diseases, Nature Communications, 2018, 9, 4092.

10.Yang Liu#, Zhi-Ting Cao#, Cong-Fei Xu*, Zi-Dong Lu,Ying-Li Luo, Jun Wang*, Optimization of lipid-assisted nanoparticlefor disturbing neutrophils-related inflammation, Biomaterials, 2018,172, 92−104.

星光领路人第8期|许从飞：每个行业都有自己的高峰期，而生物医学已至山腰